China Jo-Jo Drugstores (CJJD) has a profit margin of -3.6%, below the Healthcare sector average of 15.58%.
Get informed when a big investor buys or sells
+ FollowAs of May 2026
Trailing 12 months ending May 2026
China Jo-Jo Drugstores posts a profit margin of -3.6% as of May 2026. That compares with -13.88% in the prior-year period — up 74.0% year over year. That is below the Healthcare sector average of 15.58%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, China Jo-Jo Drugstores's profit margin was -13.88%. The latest reading is -3.6% — a 74.0% year-over-year increase (period ending May 2026). Use the history and growth charts on this page for a longer lookback.
For Healthcare stocks, a profit margin near 15.58% is typical. China Jo-Jo Drugstores's -3.6% is lower that level. That is roughly 123.1% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
China Jo-Jo Drugstores's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -3.6% as of May 2026; use YoY and peer views to separate noise from signal.
Context for CJJD's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 15.58%), and (3) consistency with growth and profitability. This page covers the first two; China Jo-Jo Drugstores's other metric pages and overview cover the third.